CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Bioverativ Inc Company Snapshot
Bioverativ Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bioverativ Inc with three other companies in this sector in the United States: Incyte Corp. (2016 sales of $1.11 billion of which 100% was Drug Discovery & Development), Medpace Holdings Inc ($370.62 million ), and Albany Molecular Research Incorporated ($570.45 million of which 61% was API).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Bioverativ Inc
  Stock Performance Chart for Bioverativ Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 63.75
(Figures in U.S. Dollars)
1 Week 14.2%   13 Weeks 19.8%  
4 Weeks 8.7%   52 Weeks 39.3%  
 
Bioverativ Inc Key Data:
  Ticker: BIVV Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 887,400,000
(Year Ending Jan 2017).
Employees: 350
  Currency: U.S. Dollars Market Cap: 6,897,741,075
  Fiscal Yr Ends: December Shares Outstanding: 108,199,860
  Share Type: Ordinary Closely Held Shares: 231,586
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.